Ana Mas

469 total citations
12 papers, 342 citations indexed

About

Ana Mas is a scholar working on Pathology and Forensic Medicine, Epidemiology and Immunology. According to data from OpenAlex, Ana Mas has authored 12 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Epidemiology and 3 papers in Immunology. Recurrent topics in Ana Mas's work include Multiple Sclerosis Research Studies (3 papers), Systemic Lupus Erythematosus Research (2 papers) and T-cell and B-cell Immunology (2 papers). Ana Mas is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), Systemic Lupus Erythematosus Research (2 papers) and T-cell and B-cell Immunology (2 papers). Ana Mas collaborates with scholars based in Spain, Belgium and Greece. Ana Mas's co-authors include Elena Urcelay, Emilio G. de la Concha, Alfonso Martínez, Rafael Artuch, Raquel Montero, Rafael Arroyo, Virginia de las Heras, Manuel Díaz‐Rubio, Antoni Capdevila and Juan L. Mendoza and has published in prestigious journals such as Blood, Annals of the Rheumatic Diseases and Movement Disorders.

In The Last Decade

Ana Mas

12 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Mas Spain 9 139 79 67 57 52 12 342
Mary Ellen Cosenza United States 9 133 1.0× 114 1.4× 50 0.7× 37 0.6× 40 0.8× 14 357
Shigeo Aoki Japan 10 90 0.6× 96 1.2× 35 0.5× 122 2.1× 37 0.7× 23 436
Shikiko Watanabe Belgium 11 141 1.0× 134 1.7× 83 1.2× 52 0.9× 53 1.0× 15 516
P Chin United States 7 132 0.9× 27 0.3× 63 0.9× 25 0.4× 38 0.7× 15 339
Eduard Gracia Spain 8 205 1.5× 79 1.0× 90 1.3× 66 1.2× 51 1.0× 16 472
Atsuko Shimizu Japan 12 299 2.2× 44 0.6× 45 0.7× 58 1.0× 48 0.9× 23 476
Zhi Fang China 14 188 1.4× 25 0.3× 61 0.9× 81 1.4× 17 0.3× 22 395
Silvia Seubert Germany 6 118 0.8× 50 0.6× 161 2.4× 53 0.9× 13 0.3× 7 394
Xiaoyi Shao China 14 150 1.1× 47 0.6× 130 1.9× 34 0.6× 19 0.4× 26 394
Takazumi Taniguchi Japan 15 257 1.8× 27 0.3× 49 0.7× 28 0.5× 37 0.7× 25 660

Countries citing papers authored by Ana Mas

Since Specialization
Citations

This map shows the geographic impact of Ana Mas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Mas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Mas more than expected).

Fields of papers citing papers by Ana Mas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Mas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Mas. The network helps show where Ana Mas may publish in the future.

Co-authorship network of co-authors of Ana Mas

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Mas. A scholar is included among the top collaborators of Ana Mas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Mas. Ana Mas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
3.
Pineda, Mercè, Raquel Montero, Ana Mas, et al.. (2010). Coenzyme Q10‐responsive ataxia: 2‐year‐treatment follow‐up. Movement Disorders. 25(9). 1262–1268. 39 indexed citations
4.
Montero, Raquel, Ana Mas, Mar O’Callaghan, et al.. (2010). Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich’s Ataxia. The Cerebellum. 10(1). 1–8. 114 indexed citations
5.
Blanco-Cañibano, E., Guillermo Moñux, Ana Mas, et al.. (2008). Role of IL-10 promoter polymorphisms in the development of severe aorto-iliac occlusive disease. Human Immunology. 69(10). 651–654. 14 indexed citations
6.
Martínez, Alfonso, Roberto Álvarez‐Lafuente, Ana Mas, et al.. (2007). Environment–gene interaction in multiple sclerosis: Human herpesvirus 6 and MHC2TA. Human Immunology. 68(8). 685–689. 29 indexed citations
7.
Martínez, Alfonso, Jezabel Varadé, Ana Mas, et al.. (2006). Role of the MHC2TA gene in autoimmune diseases. Annals of the Rheumatic Diseases. 66(3). 325–329. 47 indexed citations
8.
Martínez, Alfonso, Virginia de las Heras, Ana Mas, et al.. (2006). Sa.20. An IFNG Polymorphism Is Associated with Interferon-Beta Response in Spanish MS Patients. Clinical Immunology. 119. S111–S112. 2 indexed citations
9.
Urcelay, Elena, Juan L. Mendoza, Carmen Martín, et al.. (2005). MDR1 gene: Susceptibility in Spanish Crohnʼs disease and ulcerative colitis patients. Inflammatory Bowel Diseases. 12(1). 33–37. 54 indexed citations
10.
Urcelay, Elena, José Luis Santiago, Ana Mas, et al.. (2005). Role of interleukin 4 in Spanish multiple sclerosis patients. Journal of Neuroimmunology. 168(1-2). 164–167. 20 indexed citations
11.
Martínez, Alfonso, Ana Mas, Virginia de las Heras, et al.. (2005). Early B-cell Factor gene association with multiple sclerosis in the Spanish population. BMC Neurology. 5(1). 19–19. 10 indexed citations
12.
Mas, Ana. (2005). Agentes software y sistemas multiagente : conceptos, arquitecturas y aplicaciones. Dialnet (Universidad de la Rioja). 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026